Literature DB >> 8740452

Activation of serotonergic 5-HT1A receptor reduces Ca(2+)- and glutamatergic receptor-evoked arachidonic acid and No/cGMP release in adult hippocampus.

J Strosznajder1, M Chalimoniuk, M Samochocki.   

Abstract

Stimulation of glutamatergic NMDA receptor in adult rat hippocampal synaptoneurosomes induces statistically significant Ca(2+)-dependent liberation of arachidonic acid (AA) and nitric oxide (NO)-activated cGMP synthesis. NMDA acting for 5 min at 100 microM markedly increases, by approx. 25%, Ca(2+)-mediated AA release from phospholipids of hippocampal synaptoneurosomes. Prolonged stimulation of NMDA receptor up to 10 min has smaller stimulatory effect and enhances AA release by about 6%. Moreover, NMDA activates NO-dependent cGMP production by approx. 5 times more than the Ca2+ itself. Release of both these second messengers is completely blocked by the competitive NMDA antagonist, APV (100 microM). The NMDA-mediated cGMP elevation completely depends on NO action, and is abolished by the specific inhibitor of NO synthase, NG-nitro-L-arginine. Moreover, serotonin at 10 microM in the presence of 10 microM pargyline, potently decreases both Ca(2+)- and NMDA receptor-mediated AA and cGMP release in hippocampal synaptoneurosomes. The agonist of 5-HT1A receptor, buspirone, in a way similar to serotonin itself, counteracts the Ca(2+)- and also NMDA receptor-evoked AA release and cGMP accumulation. An antagonist of 5-HT1A receptor, NAN-190, eliminates the effect of serotonin and buspirone on AA and NO/cGMP liberation. An antagonist of serotonergic 5-HT2 receptor, ketanserin, has no effect on the Ca2+ and serotonin action. These results indicate that serotonin, through 5-HT1A receptor, potently antagonizes the action of excitatory amino acid for AA release and NO/cGMP synthesis in the adult rat hippocampus. In conclusion, the interaction of serotonin with the glutamatergic system in the hippocampus may play an important role in the modulation of a signal transduction pathway, and by this molecular mechanism serotonin may exert a neuroprotective effect on hippocampal neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740452     DOI: 10.1016/0197-0186(95)00103-4

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

1.  Regional changes of cyclic 3',5'-guanosine monophosphate in the spinal cord of the rabbit following brief repeated ischemic insults.

Authors:  J Pavel; N Lukácová; J Marsala
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

2.  Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.

Authors:  Manesh Gopaldas; Francesca Zanderigo; Serena Zhan; R Todd Ogden; Jeffrey M Miller; Harry Rubin-Falcone; Thomas B Cooper; Maria A Oquendo; Gregory Sullivan; J John Mann; M Elizabeth Sublette
Journal:  J Affect Disord       Date:  2019-07-05       Impact factor: 4.839

3.  Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Authors:  T V Zanelati; C Biojone; F A Moreira; F S Guimarães; Sâmia R L Joca
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

4.  Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice.

Authors:  Jian-Hui Liang; Xu-Hua Wang; Rui-Ke Liu; Hong-Lei Sun; Xiang-Feng Ye; Ji-Wang Zheng
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

5.  Serotonin 5-hT1A receptor activation prevents phosphorylation of NMDA receptor NR1 subunit in cerebral ischemia.

Authors:  P Salazar-Colocho; J Del Río; D Frechilla
Journal:  J Physiol Biochem       Date:  2007-09       Impact factor: 4.158

Review 6.  Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands.

Authors:  Zdzisław Chilmonczyk; Andrzej Jacek Bojarski; Andrzej Pilc; Ingebrigt Sylte
Journal:  Int J Mol Sci       Date:  2015-08-07       Impact factor: 5.923

Review 7.  The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias.

Authors:  Alfredo Costa; Fabio Antonaci; Matteo Cotta Ramusino; Giuseppe Nappi
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.